Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07820358) titled 'Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer' on Sept. 9.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: The Methodist Hospital Research Institute
Condition:
Endometrial Atypical Hyperplasia
Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia
Endometrial Cancer Stage I
Endometrial Cancer
Fertility-Sparing Treatment (FST)
Obesity & Overweight
Intervention:
Drug: Semaglutide (Wego...